Univariate Analysis (N = 35)
| Factor . | No. of Patients . | P Value . |
|---|---|---|
| Age (yr) | 35 | .097 |
| Sex | ||
| Male | 14 | .408 |
| Female | 21 | |
| Age-adjusted international index | ||
| High | 21 | .403 |
| Low | 14 | |
| Mediastinal mass size (cm) | ||
| <10 | 12 | .668 |
| ≥10 | 14 | |
| Pleural effusion at presentation | ||
| Yes | 12 | .930 |
| No | 17 | |
| B-symptoms | ||
| Yes | 16 | .480 |
| No | 18 | |
| SVC syndrome | ||
| Yes | 13 | .264 |
| No | 22 | |
| Stage at ABMT | ||
| Localized | 26 | .079 |
| Advanced | 9 | |
| Radiation therapy | ||
| Yes | 24 | .646 |
| No | 11 | |
| Extranodal sites at ABMT | ||
| Yes | 8 | .205 |
| No | 27 | |
| Chemotherapy responsiveness at ABMT | ||
| Responsive | 20 | .007 |
| Nonresponsive | 15 | |
| Disease status at ABMT | ||
| First response (CR or PR) | 12 | |
| Primarily refractory | 12 | .023 |
| Relapsed | 11 |
| Factor . | No. of Patients . | P Value . |
|---|---|---|
| Age (yr) | 35 | .097 |
| Sex | ||
| Male | 14 | .408 |
| Female | 21 | |
| Age-adjusted international index | ||
| High | 21 | .403 |
| Low | 14 | |
| Mediastinal mass size (cm) | ||
| <10 | 12 | .668 |
| ≥10 | 14 | |
| Pleural effusion at presentation | ||
| Yes | 12 | .930 |
| No | 17 | |
| B-symptoms | ||
| Yes | 16 | .480 |
| No | 18 | |
| SVC syndrome | ||
| Yes | 13 | .264 |
| No | 22 | |
| Stage at ABMT | ||
| Localized | 26 | .079 |
| Advanced | 9 | |
| Radiation therapy | ||
| Yes | 24 | .646 |
| No | 11 | |
| Extranodal sites at ABMT | ||
| Yes | 8 | .205 |
| No | 27 | |
| Chemotherapy responsiveness at ABMT | ||
| Responsive | 20 | .007 |
| Nonresponsive | 15 | |
| Disease status at ABMT | ||
| First response (CR or PR) | 12 | |
| Primarily refractory | 12 | .023 |
| Relapsed | 11 |
Patients with missing data for a given factor were excluded.